Alexion Pharmaceuticals
Anh Tran is an experienced clinical operations leader with a strong background spanning over two decades in the pharmaceutical industry. Currently serving as Executive Director and Late Phase TA Lead at Alexion Pharmaceuticals, Inc. since April 2017, Anh previously held multiple senior director roles at Pfizer from May 2004 to April 2017, focusing on rare diseases and neurosciences. Prior experience includes a position as a clinical scientist at Bristol-Myers Squibb. Anh holds a PharmD in Clinical Pharmacy from The Ohio State University and a Master of Science in Pharmacy from Uppsala University.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.